Fumiko Chino

Fumiko Chino

Auto-generated profile, based on publicly available information

Fumiko Chino

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
GSGrace Smith
Grace Smith
MBMatthew P. Banegas
Matthew P. Banegas
CAChiara Acquati
Chiara Acquati
SCShine Chang
Shine Chang
FCFumiko Chino
Fumiko Chino
KYK. Robin Yabroff
K. Robin Yabroff
Approximately one‐half of individuals with cancer face personal economic burdens associated with the disease and its treatment, a problem known as financial toxicity (FT). FT more frequently affects socioeconomically vulnerable individuals and leads to subsequent adverse economic and health outcomes. Whereas multilevel systemic factors at the policy, payer, and provider levels drive FT, there are also accompanying intervenable patient‐level factors that exacerbate FT in the setting of clinical care delivery. The primary strategy to intervene on FT at the patient level is financial navigation . Financial navigation uses comprehensive assessment of patients’ risk factors for FT, guidance toward support resources, and referrals to assist patient financial needs during cancer care. Social workers or nurse navigators most frequently lead financial navigation. Oncologists and clinical provider teams are multidisciplinary partners who can support optimal FT management in the context of their clinical roles. Oncologists and clinical provider teams can proactively assess patient concerns about the financial hardship and employment effects of disease and treatment. They can respond by streamlining clinical treatment and care delivery planning and incorporating FT concerns into comprehensive goals of care discussions and coordinated symptom and psychosocial care. By understanding how age and life stage, socioeconomic, and cultural factors modify FT trajectory, oncologists and multidisciplinary health care teams can be engaged and informative in patient‐centered, tailored FT management. The case presentations in this report provide a practical context to summarize authors’ recommendations for patient‐level FT management, supported by a review of key supporting evidence and a discussion of challenges to mitigating FT in oncology care. CA Cancer J Clin. 2022;72:437‐453.

1 May 2014 in Journal of Oncology Practice
Verified
Journal Article
Closed access
CBChristine M. Bestvina
Christine M. Bestvina
LZLeah L. Zullig
Leah L. Zullig
CRChristel Rushing
Christel Rushing
FCFumiko Chino
Fumiko Chino
GSGregory P. Samsa
Gregory P. Samsa
SZS. Yousuf Zafar
S. Yousuf Zafar
The authors conclude that patient-oncologist cost communication and financial distress were associated with medication nonadherence, suggesting that cost discussions are important for patients forced to make cost-related behavior alterations.

1 November 2017 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
FCFumiko Chino
Fumiko Chino
JPJeffrey M. Peppercorn
Jeffrey M. Peppercorn
CRChristel Rushing
Christel Rushing
AKArif H. Kamal
Arif H. Kamal
IAIvy Altomare
Ivy Altomare
SZS. Yousuf Zafar
S. Yousuf Zafar
The financial burden of cancer treatment is a well-established concern.1,2 Owing to cost sharing, even insured patients face financial burden and are at risk for worsened quality of life3 and increased mortality.4 Underinsured patients (those spending more than 10% of their income on health care costs) are a growing population,5 and are at risk given the looming heath policy and coverage changes on the horizon. In this setting, little is known about what expectations patients have regarding those costs and how those cost expectations might impact decision making.

25 March 2014 in The Oncologist
Verified
Journal Article
Open access
PDF file
FCFumiko Chino
Fumiko Chino
JPJeffrey Peppercorn
Jeffrey Peppercorn
DTDonald H. Taylor
Donald H. Taylor
YLYing Lu
Ying Lu
GSGregory Samsa
Gregory Samsa
SZS. Yousuf Zafar
S. Yousuf Zafar
Background.: Health care-related costs and satisfaction are compelling targets for quality improvement in cancer care delivery; however, little is known about how financial burden affects patient satisfaction. Methods.: This was an observational, cross-sectional, survey-based study assessing patient-reported financial burden (FB). Eligible patients were ≥21 years with solid tumor malignancy and were receiving chemotherapy or hormonal therapy for ≥1 month. The Patient Satisfaction Questionnaire Short-Form assessed patient satisfaction with health care. Subjective FB related to cancer treatment was measured on a 5-point Likert scale. Results.: Of 174 participants (32% response rate), 47% reported significant/catastrophic FB. Participants reported highest satisfaction with interpersonal manner and lowest satisfaction with financial aspects of care. In adjusted analysis, high FB was negatively associated with general satisfaction (coefficient: −.29), satisfaction with technical quality (coefficient: −.26), and satisfaction with financial aspects of care (coefficient: −.62). Older age was associated with higher scores in all satisfaction subscales except patient-physician communication and financial aspects. Annual household income of <$20,000 was associated with lower satisfaction scores in all subscales except time spent with doctor. High FB was not associated with patient satisfaction scores for accessibility and convenience, communication, interpersonal manner, or time spent with doctor. Conclusion.: FB is a potentially modifiable correlate of poor satisfaction with cancer care including general satisfaction and satisfaction with the technical quality of care. Addressing cancer-associated FB may lead to improved satisfaction, which in turn can influence adherence, outcomes, and quality of life.

1 August 2020 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
ALAnna Lee
Anna Lee
KSKanan Shah
Kanan Shah
FCFumiko Chino
Fumiko Chino
The economic and personal distress resulting from the costs of cancer treatment has been referred to as financial toxicity. Nonmedical costs such as travel expenses are almost never reimbursed by insurance and can be a substantial out-of-pocket expense. This cross-sectional study aims to report parking fees at National Cancer Institute (NCI)–designated cancer treatment centers and to assess parking costs for the treatment duration of certain cancers.

1 September 2015
Verified
Journal Article
Closed access
SZS Yousuf Zafar
S Yousuf Zafar
FCFumiko Chino
Fumiko Chino
PUPeter A Ubel
Peter A Ubel
CRChristel Rushing
Christel Rushing
GSGregory Samsa
Gregory Samsa
JPJeffery M Peppercorn
Jeffery M Peppercorn